MedTrace Logo

Effects of Corrective Exercises in Adolescent Fencers

NCT06927778 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-04-20

No results posted yet for this study

Summary

The goal is to learn if a Functional Corrective Training (FCT) exercise program improves posture, core muscle endurance, jumping ability, and reaction time in adolescent fencers.

The main questions it aims to answer are:

Does the FCT program improve trunk muscle endurance?

Does the FCT program enhance athletic performance, such as jump height and reaction time?

Researchers will compare adolescent fencers who receive an 8-week FCT exercise program to those who continue regular training only.

Participants will:

Be assigned randomly to either an exercise group (FCT) or a control group

Undergo Functional movement screen, endurance, jumping, and reaction time assessments before and after the 8-week period

Continue their usual fencing training throughout the study

The study will help determine whether adding corrective exercises to standard training can improve function and performance in young athletes.

Conditions

  • Muscle Weakness
  • Postural Imbalance
  • Athletic Performance

Interventions

OTHER

Exercise

Individualised corrective exercise protocols based on Functional Movement Screening

Sponsors & Collaborators

  • Saglik Bilimleri Universitesi

    lead OTHER

Principal Investigators

  • Seda Bicici Ulusahin, PhD · Saglik Bilimleri Universitesi

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-07-30
Completion
2024-08-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06927778 on ClinicalTrials.gov